Prof. PeptideProf. Peptide

Does BPC-157 need to be refrigerated?

Once reconstituted, yes. Clinics keep a mixed BPC-157 vial refrigerated and use it within about one to four weeks. FDA's 2026 briefing reports BPC-157 in solution stable for 2–3 weeks at 4°C, and the freeze-dried powder stable at room temperature for 3 weeks, with storage below -18°C advised for the long term.

  • FAQ
  • Recovery & Tissue Repair
  • Prof. Peptide evidence level: Human observational
  • Research use only

What FDA's briefing reports

FDA's briefing document for its July 2026 Pharmacy Compounding Advisory Committee reports that freeze-dried (lyophilized) BPC-157 is stable at room temperature for 3 weeks, but recommends storage desiccated below -18°C, because moisture greatly decreases the long-term stability of freeze-dried peptides. Once reconstituted, it reports BPC-157 in solution stable for 2–3 weeks at 4°C and for 3–4 months at -20°C1.

How clinics store it

  • One clinic stores the vial upright in the refrigerator at 35–46°F and gives reconstituted BPC-157 2–4 weeks refrigerated2.
  • Another refrigerates it after reconstitution, says the unreconstituted powder can be kept at room temperature, and ships it overnight refrigerated3.
  • A clinician-reviewed guide stores the powder in the refrigerator or freezer as directed and uses a mixed vial within the recommended window, often 7–14 days in the fridge4.

What no source establishes

None of these figures comes from a label for an approved product, because there is none: BPC-157 is not FDA-approved. FDA's figures are reported values in a briefing document, and the clinic windows differ from one another, from one to four weeks. No published study in people has tested how long a reconstituted vial keeps its potency.

How BPC-157 is reconstituted and administered is set out in How is BPC-157 taken?.

The arithmetic for each vial size and water volume is in the BPC-157 reconstitution calculator.

Research status

Human observationalLevel 3 of 4
Prof. Peptide’s evidence level records the highest study design a compound has been examined under, not whether the results were good. The full method is on the methodology page.

References

  1. BPC-157 briefing document, Pharmacy Compounding Advisory Committee, July 23–24, 2026RegulatorU.S. Food and Drug Administration.Key finding: FDA's review for the ulcerative-colitis nomination concluded there was a lack of evidence of effectiveness.fda.gov →
  2. Beyond Stem Cells Medical Spa, Littleton, Colorado. Best way to take BPC-157: the complete guide to dosing and administration; read October 26 and 29, 2026; cited for its storage figures.Source →
  3. Moonshot Medical and Performance, Park Ridge, Illinois; medically reviewed by Missy Zammichieli, DNP, APRN, FNP-BC. BPC-157: Benefits, Dosing & Side Effects (2026). Updated March 24, 2026; read October 29, 2026; cited for its storage and shipping statements.Source →
  4. Ubie Doctor's Note (Ubie Health), reviewed by Yoshinori Abe, MD, Internal Medicine. Stop Injecting BPC-157 Wrong! Joint vs. Belly? (MD Guide). Published October 7, 2026; read October 29, 2026; cited for its storage window.Source →

More on this compound

For other common questions regarding BPC-157, see the full BPC-157 profile.

Where to Buy

Capstone Peptides

✓ Lab & COAs Verified🇺🇸 US
50% off
Capstone Peptides logo

Ion Peptide

✓ Lab & COAs Verified🇺🇸 US
15% off
Ion Peptide logo

Crush Research

✓ Labs & COAs Verified🇺🇸 US
10% off
Crush Research logo

Research use only. Not medical advice.

We may earn commissions from peptide vendor affiliate links.

Updated